Clinical Trials Logo
NCT number NCT03289585
Study type Observational
Source Montefiore Medical Center
Contact Steve R Cohen, MD, MPH
Phone 7189208470
Email srcohen@montefiore.org
Status Recruiting
Phase N/A
Start date August 2015
Completion date August 2020

Clinical Trial Summary

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. We hope this information will help us improve our treatment for this skin condition


Clinical Trial Description

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. Through internet groups and the American Academy of Dermatology, we propose to enroll greater than 200 enrollees in the first two years of this project. We will utilize a compilation of validated questionnaires including the Beck Depression Inventory form, Dermatology Life Quality Index (DLQI), Skindex, SF-36 health survey, the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF) and the Employment/Productivity Health Economic Questionnaire as well as other relevant clinical data. We will additionally collect a modified Hidradenitis Suppurativa Lesion, Area, and Severity Index (HS-LASI) (or other appropriate disease severity score as determined by the team) from the physician of each enrollee.We hope this information will help us improve our treatment for this skin condition


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Active, not recruiting NCT02904902 - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Phase 3
Recruiting NCT03275870 - Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Phase 1/Phase 2
Recruiting NCT03248531 - A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Phase 2
Completed NCT00329823 - Etanercept in Hidradenitis Suppurativa Phase 2
Recruiting NCT03238469 - Microwave Ablation in Mild Axillary Hidradenitis Suppurativa N/A
Completed NCT01516749 - Anakinra as a Treatment for Hydradenitis Suppurativa Phase 2
Terminated NCT00722800 - A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS Phase 2
Completed NCT00395187 - A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa N/A
Completed NCT01838499 - Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa Phase 2
Completed NCT01704534 - A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa Phase 2
Recruiting NCT01352078 - Wound Etiology and Healing Study N/A
Recruiting NCT03054155 - Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser N/A
Completed NCT02833909 - Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients N/A
Recruiting NCT02163746 - Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing N/A
Recruiting NCT01818167 - An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa. N/A
Completed NCT01558375 - Anakinra in Hidradenitis Suppurativa Phase 2
Completed NCT02593604 - Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa N/A
Recruiting NCT03001115 - Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects N/A
Recruiting NCT03040804 - Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa N/A
Completed NCT02781818 - A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa. N/A